I am a reproductive‑age woman taking letrozole 7.5 mg from cycle day 3 to 7; my follicle‑stimulating hormone (FSH) rose to 12.2 IU/L on day 7 and fell to 2.4 IU/L on day 9, and this evening (cycle day 9 at 11 pm) I have mild lower‑abdominal cramping, a small amount of cervical mucus and light spotting—are these findings normal and what should I do?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cycle Day 9 Cramping and Spotting During Letrozole Treatment

Your symptoms of mild cramping, cervical mucus, and light spotting on cycle day 9 are expected physiologic responses to letrozole-induced ovarian stimulation and do not indicate a problem. The dramatic FSH fluctuation you describe (12.2 IU/L on day 7 dropping to 2.4 IU/L on day 9) reflects normal negative feedback as your follicles mature and produce estrogen, which is precisely how letrozole works 1.

Understanding Your Symptoms

These findings are entirely normal for this stage of your cycle:

  • Cramping on cycle day 9 represents follicular growth and stretching of the ovarian capsule as your dominant follicle(s) enlarge in response to the letrozole stimulation 1, 2.

  • Cervical mucus production indicates rising estrogen from maturing follicles—letrozole does not deplete estrogen receptors like clomiphene citrate, so normal cervical mucus production is preserved and actually indicates successful ovarian response 1.

  • Light spotting at this point in your cycle may represent either mid-cycle estrogen breakthrough bleeding as follicles mature, or early luteinizing hormone (LH) surge-related changes 3.

What These Hormone Changes Mean

  • The FSH rise to 12.2 IU/L on day 7 occurred because letrozole blocks estrogen production, removing negative feedback on your pituitary gland 1.

  • The subsequent drop to 2.4 IU/L on day 9 indicates your follicles are now producing estrogen (despite letrozole), which restores negative feedback—this is the desired effect and suggests you have responsive follicle(s) developing 1, 4.

  • This FSH pattern promotes mono- or oligo-ovulation rather than excessive multifollicular development, because estrogen receptors in your brain remain functional with letrozole (unlike with clomiphene) 1.

What You Should Do Now

Continue your current course and monitor for ovulation:

  • No intervention is needed for these symptoms—they indicate appropriate ovarian response 1, 2.

  • Begin monitoring for LH surge starting now (cycle day 9-10), as ovulation typically occurs 12-14 days after starting letrozole at your dose 4, 5.

  • Expect ovulation around cycle days 12-14 based on the typical timeline with 7.5 mg letrozole 2, 4, 5.

  • The cervical mucus you're experiencing is favorable for conception and should not be suppressed—this is an advantage of letrozole over clomiphene 1.

When to Seek Urgent Evaluation

Contact your provider immediately if you develop:

  • Severe abdominal pain or distension (could indicate ovarian hyperstimulation syndrome, though rare with letrozole) 6.

  • Heavy vaginal bleeding (more than light spotting) 3.

  • Positive pregnancy test with worsening pain (to rule out ectopic pregnancy if you conceived in a prior cycle) 3.

Important Context About Your Letrozole Dose

  • Your 7.5 mg dose is higher than standard but is supported by evidence showing increased follicular development and pregnancy rates compared to lower doses 2, 4.

  • Studies show 7.5 mg produces more mature follicles than 2.5 mg without detrimental effects on endometrial thickness 2, 4.

  • However, 7.5 mg does not show clear advantage over 5 mg in head-to-head comparisons for ovulation or pregnancy rates 5.

  • Your endometrial thickness should be monitored as letrozole combined with gonadotropins (if used) can thin the endometrium, though this is less concerning with letrozole alone 7.

Expected Timeline Going Forward

  • Ovulation should occur within 3-5 days (cycle days 12-14) based on your current symptoms and hormone pattern 4, 5.

  • Plan intercourse or insemination when LH surge is detected or when your largest follicle reaches 18 mm on ultrasound 4, 5, 7.

  • The spotting should resolve within 24-48 hours as you approach ovulation 3.

Related Questions

What is the cause of vaginal bleeding on day 14 in a female of reproductive age undergoing fertility treatment with letrozole (5mg) from day 3 to day 7?
Is the bleeding experienced by a 34-year-old woman from day 14 onwards of her menstrual cycle, after taking Letrozole (letrozole) for ovulation induction with ovulation confirmed on day 12, likely a menstrual period or something else, given the initial spotting followed by increased bleeding?
What is the proper dosage and administration of letrozole (Femara) to induce ovulation for fertility?
What is the reason to increase the letrozole (Femara) dose when using it for ovulation induction?
What is the likely cause of bleeding on days 14 and 15 in a 34-year-old female with a history of letrozole (letrozole is a non-steroidal competitive inhibitor of the aromatase enzyme, generic name) induction, who had a corpus luteum on day 12, and had sexual contact around the time of ovulation?
What is ventricular heart disease, including its types, etiologies, clinical presentation, diagnostic evaluation, and management recommendations, as described in Harrison's Principles of Internal Medicine?
How should dialysis orders be prescribed for a patient with acute kidney injury, including indications, modality selection (continuous renal replacement therapy, intermittent hemodialysis, or sustained low‑efficiency dialysis) and detailed prescription parameters such as blood flow rate, dialysate flow rate, ultrafiltration goals, anticoagulation, and target laboratory values?
What is the recommended evaluation and initial management of ascites in a patient with established liver cirrhosis?
What is the earliest clinical sign of Reye syndrome in an infant?
What is the recommended smoking cessation management for a 70‑year‑old male chronic smoker with emphysema?
When should I expect the luteinizing hormone (LH) surge after cycle day 9 in my letrozole ovulation induction cycle?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.